IMM 1.59% 31.0¢ immutep limited

3.8m euro grant, page-2

  1. 2,099 Posts.
    lightbulb Created with Sketch. 24
    "potentially broaden the clinical utility and commercial attractiveness of CVac"

    they keep saying this - somewhere, sometime, it must come to fruition, otherwise this is tokenism, imo. glta
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.